SCHEMBL219661

SCHEMBL219661

Fc1ccc(Br)c(Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29638257 1.00
Boric Acid SCHEMBL2461204 0.91 ALOX15 (0.38)
SCHEMBL29664267 0.79
SCHEMBL505116 0.79
SCHEMBL15670027 0.77 SOS1 (0.46)
SCHEMBL2840953 0.75
SCHEMBL30411804 0.75
SCHEMBL29490721 0.75
SCHEMBL14413 0.75
SCHEMBL29350499 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114790139-B Method for synthesizing 2-chloro-4-fluorobenzoic acid by taking 2-chloro-4-aminobromobenzene as raw material 江苏中旗科技股份有限公司 2024-06-18 CN claimed
CN-115010574-B Synthesis method of 1-bromo-2-chloro-4-fluoro-2-iodobenzene 爱斯特(成都)生物制药股份有限公司 2024-01-05 CN claimed
CN-115010574-A Synthesis method of 1-bromo-2-chloro-4-fluoro-2-iodobenzene 爱斯特(成都)生物制药股份有限公司 2022-09-06 CN claimed
CN-114790139-A Method for synthesizing 2-chloro-4-fluorobenzoic acid by taking 2-chloro-4-amino bromobenzene as raw material 江苏中旗科技股份有限公司 2022-07-26 CN claimed
CN-102807578-B A kind of preparation method of lithium salts BIYADI CO., LTD. (CN) 2015-12-02 CN claimed
CN-104151228-A Method for preparing N-aryl carbazole without using catalyst UNIV SHIHEZI 2014-11-19 CN claimed
JP-62114938-A None JP disclosed
US-12590062-B2 PD-1/PD-L1 inhibitors GILEAD SCIENCES, INC. (US) 2026-03-31 US disclosed
US-20260022130-A1 HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2026-01-22 US disclosed
EP-4678641-A1 QUINOLINONE COMPOUND AND NAPHTHYRIDINONE COMPOUND AND USE THEREOF Shanghai Helioson Pharmaceutical Co., Ltd. (CN) 2026-01-14 EP disclosed
WO-2025245089-A1 PROCESSES FOR PREPARING TETRALIN COMPOUNDS ARCUS BIOSCIENCES, INC. (US) 2025-11-27 WO disclosed
EP-4652154-A1 NOVEL ALPK1 INHIBITORS Pyrotech (Beijing) Biotechnology Co., Ltd. (CN) 2025-11-26 EP disclosed
US-20250333406-A1 SULFONYL CYCLIC DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF LYSOWAY THERAPEUTICS INC (US) 2025-10-30 US disclosed
US-20050070539-A1 Benzoyl-piperazine derivatives F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2005-03-31 US disclosed
WO-2005023260-A1 1- (2-AMINO-BENZOL) -PIPERAZINE DERIVATIVES AS GLYCINE UPTAKE INHIBITORS FOR THE TREATMENT OF PSYCHOSES F. HOFFMANN-LA ROCHE AG (CH) 2005-03-17 WO disclosed
WO-2005009940-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA A/S (DK) 2005-02-03 WO disclosed
JP-S62114938-A 1-BROMO-2-CHLORO-4-FLUORO-5-NITROBENZENE AND PRODUCTION THEREOF SUMITOMO CHEM CO LTD 1987-05-26 JP disclosed
EP-0109606-B1 PROCESS FOR THE FORMYLATION OF ARYL HALIDES BAYER AG (DE) 1986-01-22 EP disclosed
US-4536344-A USING A PHOSPINE OR PHOSPHITE BAYER AKTIENGESELLSCHAFT (DE) 1985-08-20 US disclosed
EP-0109606-A1 Process for the formylation of aryl halides BAYER AG (DE) 1984-05-30 EP disclosed